当前位置: 首页 > 期刊 > 《国际神经病学神经外科学杂志》 > 2004年第5期 > 正文
编号:11355103
We move: www.wemove.org
http://www.100md.com 《神经病学神经外科学杂志》
     Department of Neurology, Derriford Hospital, Derriford, Plymouth PL6 8DH, UK; martin.sadler@phnt.swest.nhs.uk

    Keywords: review; website

    This snappily named site claims to be the internet’s most comprehensive resource for movement disorder information and the hub of movement disorder activities on the web. It is certainly a very well presented and useful site. There are a number of free services on offer. There is a movement disorder research news email update service (E-MOVE), links to other, mainly American, sites and support groups, both a chat room and forum (for which you have to register), and a link to movement disorder virtual university (MDVU). This is a closely related site that has an even snappier appearance than the original We move site but actually contains much of the same information under the topic headings. On the We move site these are listed on 21 buttons down the left edge. There is an interesting mix of the expected diseases, such as Parkinson’s; general, non-disease specific problems, such as tremor (which then covers paediatric tremor); and other slightly unexpected topics such as spasticity, Huntington’s disease, and Rett syndrome. The information on each topic is well organised and reasonably current. The site is funded by a long list of pharmaceutical companies and the treatment section of each subject is peppered with their branded products in addition to the generic names. The American parentage of the site is also reflected in the suggested use of drugs unavailable in the UK, such as tolcapone. Strangely, considering its title and subject, what the site lacks is movement in the form of video clips. There is an animated clip of how botulinum toxin works but this took long enough, across a broadband connection, for me to make a cup of tea before it started. Overall though, it is a great place to start on the web for movement disorders information.(M Sadler)